# US 2025/0154159 A1 · CYCLIC Gd (III) COMPLEX AND PREPARATION METHOD AND USE THEREOF

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0154159 A1
- Document ID: US20250154159A1
- Status: Published application
- Kind: A1
- Application number: 17/997,450
- Filed: 2022-06-23
- Published: 2025-05-15
- Earliest claimed: 2022-03-16
- Assignees: Wenzhou Institute, University of Chinese Academy Of Sciences
- Applicants: Wenzhou Institute University of Chinese Academy of Sciences
- Inventors: Lixiong DAI; Weiyuan XU; Fangfu YE
- Web page: https://patentgrep.com/patent/US20250154159A1

## CPC

- C07D 257/02: not condensed with other rings
- C07D 487/22: in which the condensed system contains four or more hetero rings
- A61K 49/106: {the complex-forming compound being cyclic, e.g. DOTA}
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present disclosure provides a cyclic Gd (III) complex with a chemical structure shown in formula I, where a ring structure of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) is used as a parent ring, lipophilic groups R′ and R″ in formula I are respectively introduced to a α-position of phenylacetic acid (PAA) and a benzene ring structure, and a chiral group R in formula I is introduced to a DOTA macrocycle position. The chiral group R can increase the rigidity of a macrocyclic structure and improve the stability of the complex, and the lipophilic groups R′ and R″ can bind to hepatocellular organic anion transporting polypeptides (OATPs), thereby greatly improving the distribution of the cyclic Gd (III) complex as a contrast agent in the liver and gallbladder, that is, thereby providing excellent targetability.

## Claims

### Claim at position 1

1-15. (canceled)

### Claim 16

A cyclic Gd (III) complex with a chemical structure shown in formula I:
wherein R in formula I is selected from the group consisting of H, C1-C4 alkyl, —CH2OH, —CH(CH3)OH, —CH2CH2OH, —CH2Ph, —(CH2)2Ph, —(CH2)3Ph, —(CH2)3NH2, and —(CH2)4Ph, and R in formula I has a configuration independently of S or R;
R″ in formula I is at an ortho, meta, or para position of a benzene ring;
R′ and R″ in formula I are each independently selected from the group consisting of H, C1-C10 alkyl, fluorine, chlorine, bromine, iodine, —CF3, —CCl3, —CBr3, C1-C10 alkoxy, —COOH, —R1COOH, —COOR1, -Ph, —NO2, substituted phenyl, —R1-Ph, —R1NO2, —OR1-Ph, —CONHR3,
—SO2—R4, and —SO—R5;
R1 in each of —R1COOH, —COOR1, —R1-Ph, —R1NO2, and —OR1-Ph is independently C1-C5 alkyl;
a substituent on the substituted phenyl is selected from the group consisting of C1-C5 alkyl, fluorine, chlorine, bromine, iodine, —CF3, —CCl3, —CBr3, C1-C5 alkoxy, —COOH, —R2COOH, —COOR2, -Ph, —R2NO2, —OR2-Ph, —CONHR2, —SO2-R2, and —SO—R2, and R2 in each of —R2COOH, —COOR2, -Ph, —R2NO2, —OR2-Ph, —CONHR2, —SO2—R2, and —SO—R2 is independently C1-C3 alkyl;
R3, R4, and R5 respectively in —CONHR3, —SO2—R4, and —SO—R5 are each independently C1-C5 alkyl or benzyl; and
M+ in formula I is a metal cation or a glucosamine cation.

### Claim 17 (depends on 16)

The cyclic Gd (III) complex according to claim 16, wherein R in formula I is selected from the group consisting of H, —CH3, —CH2CH3, —CH(CH3)2, —CH(CH3)OH, —CH2Ph, and (CH2)4Ph;
R′ and R″ in formula I are each independently selected from the group consisting of H, —COOH, CONHR3, —CF3, —C(CH3)3, -Ph, —NO2, —OBn,
—SO2—R4, and —SO—R5; and
R3, R4, and R5 respectively in —CONHR3, —SO2—R4, and —SO—R5 are each independently C1-C5 alkyl or benzyl.

### Claim 18 (depends on 16)

The cyclic Gd (III) complex according to claim 16, wherein M+ in formula I is selected from the group consisting of Na+, K+, Li+, and a glucosamine cation.

### Claim 19 (depends on 16)

A preparation method of the cyclic Gd (III) complex according to claim 16, wherein in formula I, R is selected from the group consisting of C1-C4 alkyl, —CH2OH, —CH(CH3)OH, —CH2CH2OH, —CH2Ph, —(CH2)2Ph, —(CH2)3Ph, —(CH2)3NH2, and —(CH2)4Ph, R′ is H, and R″ is
and the preparation method comprises the following steps:
1) mixing a compound with a structure shown in formula A-1, a compound with a structure shown in chiral cyclen, and acetonitrile to allow a first nucleophilic substitution reaction to obtain a compound with a structure shown in formula D-2;
2) in a nitrogen atmosphere, mixing the compound with a structure shown in formula D-2 obtained in step 1), acetonitrile, potassium carbonate, and tert-butyl bromoacetate to allow a second nucleophilic substitution reaction to obtain a compound with a structure shown in formula D-3;
3) mixing the compound with a structure shown in formula D-3 obtained in step 2), THF, methanol, and a lithium hydroxide aqueous solution to allow an ester hydrolysis reaction to obtain a third reaction precursor;
4) in a nitrogen atmosphere, mixing the third reaction precursor obtained in step 3) with HATU, DCM, an amine compound, and DIPEA to allow a condensation reaction to obtain a compound with a structure shown in formula D-4;
5) in a nitrogen atmosphere, mixing the compound with a structure shown in formula D-4 obtained in step 4) and TFA to allow a t-butyl ester group removal reaction to obtain a compound with a structure shown in formula D-5; and
6) mixing the compound with a structure shown in formula D-5 obtained in step 5), a gadolinium source, water, and an M+-containing solution to allow a complexation reaction to obtain the cyclic Gd (III) complex,
wherein the M+-containing solution in step 6) is a solution of a metal hydroxide or a glucosamine,

### Claim 20 (depends on 19)

The preparation method according to claim 19, wherein R in formula I is selected from the group consisting of H, —CH3, —CH2CH3, —CH(CH3)2, —CH(CH3)OH, —CH2Ph, and (CH2)4Ph;
R′ and R″ in formula I are each independently selected from the group consisting of H, —COOH, CONHR3, —CF3, —C(CH3)3, -Ph, —NO2, —OBn,
—SO2—R4, and —SO—R5; and
R3, R4, and R5 respectively in —CONHR3, —SO2—R4, and —SO—R5 are each independently C1-C5 alkyl or benzyl.

### Claim 21 (depends on 19)

The preparation method according to claim 19, wherein M+ in formula I is selected from the group consisting of Na+, K+, Li+, and a glucosamine cation.

### Claim 22 (depends on 19)

The preparation method according to claim 19, wherein the ester hydrolysis reaction in step 3) is conducted at room temperature for 4 h to 8 h.

### Claim 23 (depends on 20)

The preparation method according to claim 20, wherein the ester hydrolysis reaction in step 3) is conducted at room temperature for 4 h to 8 h.

### Claim 24 (depends on 21)

The preparation method according to claim 21, wherein the ester hydrolysis reaction in step 3) is conducted at room temperature for 4 h to 8 h.

### Claim 25 (depends on 16)

A preparation method of the cyclic Gd (III) complex according to claim 16, wherein in formula I, R is selected from the group consisting of C1-C4 alkyl, —CH2OH, —CH(CH3)OH, —CH2CH2OH, —CH2Ph, —(CH2)2Ph, —(CH2)3Ph, —(CH2)3NH2, and —(CH2)4Ph, R′ is H, and R″ is selected from the group consisting of H, —CF3, —C(CH3)3, -Ph, —NO2, and —OBn; and the preparation method comprises the following steps:
(1′) in a nitrogen atmosphere, mixing a compound with a structure shown in formula E-1, a compound with a structure shown in chiral cyclen, and acetonitrile to allow a first nucleophilic substitution reaction to obtain a compound with a structure shown in formula E-2;
(2′) in a nitrogen atmosphere, mixing the compound with a structure shown in formula E-2 obtained in step (1′), acetonitrile, potassium carbonate, and ethyl bromoacetate to allow a second nucleophilic substitution reaction to obtain a compound with a structure shown in formula E-3;
(3′) mixing the compound with a structure shown in formula E-3 obtained in step (2′), THE, methanol, and a lithium hydroxide aqueous solution to allow an ester hydrolysis reaction, and subjecting a product of the ester hydrolysis reaction to concentration, dilution, and pH adjustment successively to obtain a compound with a structure shown in formula E-4; and
(4′) mixing the compound with a structure shown in formula E-4 obtained in step (3′), a gadolinium source, water, and an M+-containing solution to allow a complexation reaction to obtain the cyclic Gd (III) complex,
wherein the M+-containing solution in step (4′) is a solution of a metal hydroxide or a glucosamine,

### Claim 26 (depends on 25)

The preparation method according to claim 25, wherein R in formula I is selected from the group consisting of H, —CH3, —CH2CH3, —CH(CH3)2, —CH(CH3)OH, —CH2Ph, and —(CH2)4Ph;
R′ and R″ in formula I are each independently selected from the group consisting of H, —COOH, CONHR3, —CF3, —C(CH3)3, -Ph, —NO2, —OBn,
—SO2—R4, and —SO—R5; and
R3, R4, and R5 respectively in —CONHR3, —SO2—R4, and —SO—R5 are each independently C1-C5 alkyl or benzyl.

### Claim 27 (depends on 25)

The preparation method according to claim 25, wherein M+ in formula I is selected from the group consisting of Na+, K+, Li+, and a glucosamine cation.

### Claim 28 (depends on 25)

The preparation method according to claim 25, wherein the complexation reaction in step (4′) is conducted at 90° C. to 110° C. for 5 h to 7 h.

### Claim 29 (depends on 26)

The preparation method according to claim 26, wherein the complexation reaction in step (4′) is conducted at 90° C. to 110° C. for 5 h to 7 h.

### Claim 30 (depends on 27)

The preparation method according to claim 27, wherein the complexation reaction in step (4′) is conducted at 90° C. to 110° C. for 5 h to 7 h.
